One of the peculiarities of the CDC’s recommendation, apart from the calculations on which it is based, is the non-consideration of alternative approaches to vaccination for adolescents outside the same exact dose and schedule as for adults. The CDC analysis “assumes that single doses of mRNA vaccines have a 0 percent efficacy in preventing Covid-19-related hospitalization,” wrote Wes Pegden, a mathematician at Carnegie Mellon University.
Although many media reports on a study published in mid-June by the British Public Health Agency highlighted her finding that two doses of Pfizer vaccine 96 percent protected against hospitalization from the Delta variant, many failed to mention that it found and that one dose was 94 percent protective. Considering the benefits of just one dose and that most of the risk of myocarditis comes from another dose, critics have suggested a number of different plans that would mitigate the risks for adolescents. Pegden, along with several co-authors, including an epidemiologist, two cardiologists and a pediatrician, also wrote a separate essay criticizing the CDC’s “all or nothing” approach, citing several alternatives. Monica Gandhi, a infectious disease doctor from UCSF, is suggested various possibilities. This includes adolescents, or especially young men, who receive only one dose; giving a second dose later, as expanding the dose may reduce the likelihood of a serious reaction; recommending vaccination only for high-risk young people; and for all adolescents who have immunity from previous infection, or only one dose or no vaccine at all, at least in the foreseeable future, from previous infection gives strong immunity.
Despite a British study, less than two weeks after it was released, Walensky said that “data from the UK shows that one shot really fails to bounce so well, especially the Delta variant, and you really need that other shot. “Two shots provide more protection than one, and it’s not yet clear whether protection from a single dose can weaken faster or not be sufficiently protective at some later date. But the CDC’s special focus on getting every American to receive two doses, including those at significantly higher risk after the second dose, like young men, seems unnecessary and perhaps harmful myopic.
Further to this point, the board meeting slide recommended that even if someone gets myocarditis after the first dose of mRNA vaccine, if the heart recovers, you should still consider receiving a second dose. While some politicians from politics were satisfied with this advice, numerous cardiologists i second medical professionals convicted to. Venk Murthy, a cardiologist at the University of Michigan, commented: “A patient with myocarditis should basically never get a second dose, even if the heart recovers. The CDC misunderstood this. “Doctors at three different major university hospitals in New York and California, who were not authorized to speak publicly, told me this advice was“ crazy ”.
The medical facility also fell in line behind the CDC to support its suspicious messages. In an extraordinary demonstration of uniformity, of the wrist statement, signed by the heads of the CDC, the American Academy of Pediatrics, the American Heart Association, the American Medical Association, the American Nurses Association, the American Hospital Association and 11 other national medical organizations, was released in response to the advisory board meeting. Partly reads:
The CDC Immunization Practices Advisory Committee (ACIP) met today to discuss the latest data on reports of milder cases of inflammation of the heart muscle and surrounding tissue called myocarditis and pericarditis after Covid-19 vaccination among younger people.